MLANAmelan-A
Autism Reports / Total Reports
4 / 4Rare Variants / Common Variants
3 / 0Aliases
MLANA, MART-1, MART1Associated Syndromes
-Chromosome Band
9p24.1Associated Disorders
-Relevance to Autism
A de novo nonsense variant in the MLANA gene was identified in an ASD proband from the Simons Simplex Collection (Iossifov et al., 2014), while transmitted protein-truncating variants (PTVs) in this gene were observed in ASD probands from the Autism Sequencing Consortium and the iHART cohort (De Rubeis et al., 2014; Ruzzo et al., 2019). TADA analysis of de novo and transmitted variants from iHART, the Simons Simplex Collection, the Autism Sequencing Consortium, and the Autism Genome Project in Ruzzo et al., 2019 identified MLANA as an ASD candidate gene with a false discovery rate (FDR) < 0.1.
Molecular Function
Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.
External Links
SFARI Genomic Platforms
Reports related to MLANA (4 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | Synaptic, transcriptional and chromatin genes disrupted in autism | De Rubeis S , et al. (2014) | Yes | - |
2 | Primary | The contribution of de novo coding mutations to autism spectrum disorder | Iossifov I et al. (2014) | Yes | - |
3 | Recent Recommendation | Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks | Ruzzo EK , et al. (2019) | Yes | - |
4 | Support | - | Cirnigliaro M et al. (2023) | Yes | - |
Rare Variants (3)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.76G>T | p.Glu26Ter | stop_gained | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
c.151C>T | p.Arg51Ter | stop_gained | Familial | Paternal | Multiplex | 31398340 | Ruzzo EK , et al. (2019) | |
c.32_42del | p.Gly11GlufsTer11 | frameshift_variant | Familial | Maternal | Multiplex | 37506195 | Cirnigliaro M et al. (2023) |
Common Variants
No common variants reported.
SFARI Gene score
Strong Candidate


A de novo nonsense variant in the MLANA gene was identified in an ASD proband from the Simons Simplex Collection (Iossifov et al., 2014), while transmitted protein-truncating variants (PTVs) in this gene were observed in ASD probands from the Autism Sequencing Consortium and the iHART cohort (De Rubeis et al., 2014; Ruzzo et al., 2019). TADA analysis of de novo and transmitted variants from iHART, the Simons Simplex Collection, the Autism Sequencing Consortium, and the Autism Genome Project in Ruzzo et al., 2019 identified MLANA as an ASD candidate gene with a false discovery rate (FDR) < 0.1.
Score Delta: Score remained at 2
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
4/1/2022

Decreased from 3 to 2
Description
A de novo nonsense variant in the MLANA gene was identified in an ASD proband from the Simons Simplex Collection (Iossifov et al., 2014), while transmitted protein-truncating variants (PTVs) in this gene were observed in ASD probands from the Autism Sequencing Consortium and the iHART cohort (De Rubeis et al., 2014; Ruzzo et al., 2019). TADA analysis of de novo and transmitted variants from iHART, the Simons Simplex Collection, the Autism Sequencing Consortium, and the Autism Genome Project in Ruzzo et al., 2019 identified MLANA as an ASD candidate gene with a false discovery rate (FDR) < 0.1.
10/1/2019

Decreased from 4 to 3
New Scoring Scheme
Description
A de novo nonsense variant in the MLANA gene was identified in an ASD proband from the Simons Simplex Collection (Iossifov et al., 2014), while transmitted protein-truncating variants (PTVs) in this gene were observed in ASD probands from the Autism Sequencing Consortium and the iHART cohort (De Rubeis et al., 2014; Ruzzo et al., 2019). TADA analysis of de novo and transmitted variants from iHART, the Simons Simplex Collection, the Autism Sequencing Consortium, and the Autism Genome Project in Ruzzo et al., 2019 identified MLANA as an ASD candidate gene with a false discovery rate (FDR) < 0.1.
Reports Added
[New Scoring Scheme]7/1/2019

Increased from to 4
Description
A de novo nonsense variant in the MLANA gene was identified in an ASD proband from the Simons Simplex Collection (Iossifov et al., 2014), while transmitted protein-truncating variants (PTVs) in this gene were observed in ASD probands from the Autism Sequencing Consortium and the iHART cohort (De Rubeis et al., 2014; Ruzzo et al., 2019). TADA analysis of de novo and transmitted variants from iHART, the Simons Simplex Collection, the Autism Sequencing Consortium, and the Autism Genome Project in Ruzzo et al., 2019 identified MLANA as an ASD candidate gene with a false discovery rate (FDR) < 0.1.
Krishnan Probability Score
Score 0.54027643446132
Ranking 1443/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 1.0761671422261E-8
Ranking 16179/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.14585116656279
Ranking 84/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score -0.26157682321432
Ranking 16584/20870 scored genes
[Show Scoring Methodology]